The dose-response relation and cost-effectiveness of granisetron for the prophylaxis of pediatric postoperative emesis

Anesthesiology

Volumn 85, Issue 5, 1996, Pages 1076-1085

  Cieslak, Gary D ^a   Watcha, Mehernoor F ^b,c   Phillips, Michael B ^c   Pennant, John H ^a  

^a Department of Anesthesiology ^*  (United States)

^b Pediatric Anesthesia Research   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anesthesia, ambulatory: pediatrics; Antiemetics: granisetron; Complications: postoperative vomiting; Economics: drugs

Indexed keywords

FENTANYL; GRANISETRON; HALOTHANE; ISOFLURANE; MIDAZOLAM; NITROUS OXIDE; VECURONIUM;

AMBULATORY SURGERY; ANESTHESIA COMPLICATION; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG COST; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENERAL ANESTHESIA; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDICAL DECISION MAKING; NAUSEA; PEDIATRIC SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING; VOMITING;

ADOLESCENT; ANTIEMETICS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRANISETRON; HUMANS; MALE; NAUSEA; PARENTS; POSTOPERATIVE COMPLICATIONS; VOMITING;

EID: 0029913544     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199611000-00016     Document Type: Article

References (37)

1. Kenny GNC: Risk factors for postoperative nausea and vomiting. Anaesthesia 1994; 49:6-10
2. Pearman MH: Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting. Anaesthesia 1994; 49(suppl):11-5
3. Watcha MF, Bras PJ, Cieslak GD, Pennant JH: The dose response relationship of ondansetron in preventing postoperative emesis in pediatric patients undergoing ambulatory surgery. ANESTHESIOLOGY 1995; 82:47-52
4. Markham A, Sorkin EM: Ondansetron: An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting. Drugs 1993; 45:931-52
5. Mikawa K, Takao Y, Nishina K, Mackawa N, Obara H: The antiemetic efficacy of prophylactic granisetron in gynecologic surgery. Anesth Analg 1995; 80:970-4
6. Fujii Y, Tanaka H, Toyooka H: Reduction of postoperative nausea and vomiting with granisetron. Can J Anaesth 1994; 41:291-4
7. Fujii Y, Tanaka H, Toyooka H: Optimal anti-emetic dose of granisetron for preventing postoperative nausea and vomiting. Can J Anaesth 1994; 41:794-7
8. Fujii Y, Tanaka H, Toyooka H: Granisetron-dexamethasone combination reduces postoperative nausea and vomiting. Can J Anaesth 1995; 42:387-90
9. Fujii Y, Tanaka H, Toyooka H: Granisetron reduces vomiting after strabismus surgery and tonsillectomy in children. Can J Anaesth 1996; 43:35-8
10. Palmer R: Efficacy and safety of granisetron (Kytril) in two special patient populations: Children and adults with impaired hepatic function. Semin Oncol 1994; 21:22-5
11. Miyajima Y, Numata S, Katayama I, Horibe K: Prevention of chemotherapy-induced emesis with granisetron in children with malignant diseases. Am J Pediatr Hematol Oncol 1994; 16:236-41
12. Perez EA, Gandara DR: The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis. Semin Oncol 1994; 21:15-21
13. Soukop M: Clinical experience with intravenous granisetron. Anticancer Drugs 1994; 5:281-6
14. Navari R, Gandara D, Hesketh P, Hall S, Mailliard J, Ritter H, Friedman C, Fitts D: Comparative clinical trial of granisetron and ondansetron in the prophylaxis of cisplatin-induced emesis. The Granisetron Study Group. J Clin Oncol 1995; 13:1242-8
15. Johnson N, Bosanquet N: Cost effectiveness of 5-hydroxytryptamine3 receptor antagonists: A retrospective comparison of ondansetron and granisetron. Anticancer Drugs 1995; 6:243-9
16. Watcha MF, White PF: Postoperative nausea and vomiting: Its etiology, treatment and prevention. ANESTHESIOLOGY 1992; 77:162-84
17. Lerman J: Surgical and patient factors involved in postoperative nausea and vomiting. Br J Anaesth 1992; 69(suppl 1):24S-32S
18. Hannallah RS, Broadman LM, Belman AB, Abramowitz MD, Epstein BS: Comparison of caudal and ilio-inguinal/ilio-hypogastric nerve blocks for the control of post-orchidopexy pain in pediatric ambulatory surgery. ANESTHESIOLOGY 1987; 66:832-4
19. Sacristan JA, Day SJ, Navarro O, Rose J, Hernandez JM: Use of confidence limits and sample size calculations in health economic studies. Ann Pharmacother 1995; 29:719-25
20. Roila F, Ballatori E, Delfavero A: Antiemetic properties of granisetron - Reply. N EngI J Med 1995; 332:1653-4
21. Jones AL, Lee GJ, Bosanquet N: The budgetary impact of 5-HT3 receptor antagonists in the management of chemotherapy-induced emesis. Eur J Cancer 1993; 29A:51-6
22. Kattlove H: Antiemetic properties of granisetron [letter]. N Engl J Med 1995; 332:1653
23. Pinkerton CR, Jacobson SJ, Leclerc JM, Cohn R, Cedar E: IV granisetron in children receiving highly emetogenic chemotherapy: A double blind dose-ranging study [abstract]. Eur J Cancer 1993; 29A:S200 (abstract 1118)
24. van Wijngaarden I, Tulp MTM, Soudijn W: The concept of selectivity in 5 HT receptor research. Eur J Pharmacol 1990; 188:301-12
25. Ito H, Akuzawa S, Tsutsumi R, Kiso T, Kamato T, Nishida A, Yamano M, Miyata K: Comparative study of the affinities of the 5-HT3 receptor antagonists, YM060, YM114 (KAE-393), granisetron and ondansetron in rat vagus nerve and cerebral cortex. Neuropharmacology 1995; 34:631-7
26. Noble A, Bremer K, Goedhals L, Cupissol D, Duly SG: A double-blind, randomised, crossover comparison of granisetron and ondansetron in 5-day fractionated chemotherapy: Assessment of efficacy, safety and patient preference. The Granisetron Study Group. Eur J Cancer 1994; 30A:1083-8
27. Paech MJ, Paevi TJG, Evans SF: Single-dose prophylaxis for postoperative nausea and vomiting after major abdominal surgery: Ondansetron versus droperidol. Anaesth Intensive Care 1995; 23:548-54
28. Davis PJ, McGowan FX, Landsman I, Maloney K, Hoffmann P: Effect of antiemetic therapy on recovery and hospital discharge time. ANESTHESIOLOGY 1995; 83:956-60
29. Chung F: Recovery pattern and home-readiness after ambulatory surgery. Anesth Analg 1995; 80:896-902
30. Orkin FK: Moving towards value based anesthesia care. J Clin Anesth 1993; 5:91-8
31. Finkler SA: The distinction between costs and charges. Ann Intern Med 1982; 96:102-9
32. Harrison BR, Godefroid RJ: Relative costs of granisetron and ondansetron [letter]. Am J Hosp Pharm 1994; 51:2196-2205
33. Evans RG: Manufacturing consensus, marketing truth: Guidelines for economic evaluations. Ann Intern Med 1995; 123:59-60
34. Lubarsky J: Understanding cost analyses: Part I. A practitioner's guide for economic evaluations. J Clin Anesth 1995; 7:518-21
35. Dexter F, Tinker JH: Analysis of strategies to decrease postanesthetic care unit costs. ANESTHESIOLOGY 1995; 82:94-101
36. White PF, White LD: Cost containment in the operating room: Who is responsible? J Clin Anesth 1994; 6:351-6
37. Ware JE Jr: What information do consumers want and how will they use it? Med Care 1995; 33JS25-30